Showing results (1371-1380 of 1,535) with videos related to

Sort By:
Pageof 154
European Radiology|February 27, 2025
AI-powered prostate cancer detection: a multi-centre, multi-scanner validation studyFrancesco Giganti, Nadia Moreira da Silva, Michael Yeung, et al.
International Journal of Rheumatic Diseases|December 21, 2021
2021 Asia-Pacific League of Associations for Rheumatology clinical practice guideline for treatment of goutJose Paulo P Lorenzo, Ma Hanna Monica Z Sollano, Evelyn O Salido, et al.
Clinical Immunology (Orlando, Fla.)|June 8, 2014
Humoral immunity induced by mucosal and/or systemic SIV-specific vaccine platforms suggests novel combinatorial approaches for enhancing responsesDiego A Vargas-Inchaustegui, Iskra Tuero, Venkatramanan Mohanram, et al.
Genome Biology|November 2, 2019
Optimizing sequencing protocols for leaderboard metagenomics by combining long and short readsJon G Sanders, Sergey Nurk, Rodolfo A Salido, et al.
Scientific Reports|June 3, 2024
Creation of an international laboratory network towards global microplastics monitoring harmonisationAdil Bakir, Alexandra R McGoran, Briony Silburn, et al.
JMIR Public Health and Surveillance|June 3, 2020
The Oxford Royal College of General Practitioners Clinical Informatics Digital Hub: Protocol to Develop Extended COVID-19 Surveillance and Trial PlatformsSimon de Lusignan, Nicholas Jones, Jienchi Dorward, et al.
European Urology Focus|October 13, 2020
The "Is mpMRI Enough" or IMRIE Study: A Multicentre Evaluation of Prebiopsy Multiparametric Magnetic Resonance Imaging Compared with BiopsyThomas Stonier, Nick Simson, Taimur Shah, et al.
Plos Pathogens|March 13, 2020
Engagement of monocytes, NK cells, and CD4+ Th1 cells by ALVAC-SIV vaccination results in a decreased risk of SIVmac251 vaginal acquisitionGiacomo Gorini, Slim Fourati, Monica Vaccari, et al.
The Lancet. Global Health|June 16, 2019
Global impact of rotavirus vaccine introduction on rotavirus hospitalisations among children under 5 years of age, 2008-16: findings from the Global Rotavirus Surveillance NetworkNegar Aliabadi, Sébastien Antoni, Jason M Mwenda, et al.
Nature Medicine|April 3, 2023
Lorlatinib with or without chemotherapy in ALK-driven refractory/relapsed neuroblastoma: phase 1 trial resultsKelly C Goldsmith, Julie R Park, Kimberly Kayser, et al.
Pageof 154